5
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 675-689 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Theory for morphology dependent resonances in the Raman spectra of optically levitated dielectric microspheres. HARTMANN, I., POPP, J., LANKERS, M., TRUNK, M., and KIEFER, W., J. Mol. Struct., 1995, 349, 203–206.
  • Thermonuclear burn performance of volume-ignited and centrally ignited bare deuterium-tritium microspheres. ATZENI, S., ypn. J. Appl. Phys., Part 1, 1995, 34, (4A), 1980–1992.
  • Preparation and characterization of ethyl cellulose-walled theophylfine microcapsules using the emulsion-solvent evaporation technique. AMPERIADOU, A., and GEORGARAKIS, M., Drug Dev. Ind. Pharm., 1995, 21, (11), 1339–1346.
  • Preparation and in vitro evaluation of tetrandrine-entrapped albumin microspheres as an inhaled delivery system. ZENG, X. M., MARTIN, G. P., MARRIOTT, C., Eur. J. Pharm. Sci., 3, (2), 87–93.
  • Effect of stearate on dispersibility and dissolution of Eudragit sulfadimidine microcapsules. ZHANG, X., JIANG, W., and Zou, L., Zhongguo Yiyao Gongye Zazhi, 1994, 25 (11), 498–501.
  • Sustained-release injection of microencapsulated compound levonorgestrel. Liu, C., and Lu, B., Zhongguo Yiyao Gongye Zazhi, 1994, 25, (11), 494–498.
  • A new procedure for the preparation of liposomal doxorubicin: Biological activity in multidrug-resistant tumor cells. THIERRY, A. R., RAHMAN, A., DRITSCHILO, A., Cancer Chemother. Pharmacol.., 1994, 35, (1), 84–88.
  • Liposomal formulations of a novel antiumor agent: drug loading and optimization. PAVLIV, L., TYLE, P., and JOHNSTON, A., PDA J. Pharm. Sci. Technol., 1995, 49, (1), 9–12.
  • In vitro release of disopyramide from cellulose acetate butyrate microspheres. RADWAN, M. A., PRICE, J. C., and TACKETT, R. L., Drug Dev. Ind. Pharm., 1995, 21, (12), 1453–1462.
  • Physicochemical evaluation of acetylsalicyclic acid-Eudragit RS100 microspheres prepared using a solvent-partition method. VACHON, M. G., and NAIRN, J. G.,y. Microcapsulation, 1995, 12, (3), 287–305.
  • Graduation of microcapsule wall porosity by deposition of polymer mixtures (Eudragit RL and Eudragit RS). Phase separation of polymer mixtures and effects of external media conditions on release. DONBROW, M., HOFFMAN, A., and BENITA, S., J. Microencapsulation, 1995, 12, (3), 273–285.
  • Surface modification of albumin microspheres. SHAFI, Z. B., MARTIN, G. P., OLLIFF, C. J., and JAMES, S. L., J. Drug Targeting, 1995, 3, (1), 53–56.
  • The in vitro characterization and biodistribution of some nonionic surfactant-coated liposomes in the rabbit. KHATTAB, M. A., FARR, S. J., TAYLOR, G., and KELLAWAY, I. W., J. Drug Targeting, 1995, 3, (1), 39–49.
  • The effect of dose on the distribution of adriamycin encapsulated in polyethylene glycol-coated liposomes. SADZUKA, Y NAKAI, S., MIYAGISHIMA, A., NOZAWA, Y., and HIROTA, S., J. Drug Targeting, 1995, 3, (1), 31–37.
  • Development and validation of a drug release rate method for a water soluble drug in a liposome preparation. VEmuRi, S., and RHODES, C. T., Drug Dev. Ind. Pharm., 1995, 21, (11), 1353–1364.
  • Methods for assessing splenic macrophage depletion by liposome encapsulated clodronate. CAMILLERI, J. P., WILLIAMS, A. S., Amos, N., DOUGLAS, J. A. G., LOVE, W. G., and WILLIAMS, B. D., Inflammation Res., 1995, 44, (4), 152–157.
  • Immunogenicity of immunoliposomes: reactivity against species-specific IgG and liposomal phospholipids. PHILLIPS, N. C., and DAHMAN, J., Immunol. Lett., 1995, 45, (3), 149–152.
  • In vitro evaluation of drug release kinetics from liposomes by fractional dialysis. HENRIKSEN, I., SANDE, S. A., SMISTAD, G., AGREN, T., and KARLSEN, J., Int. J. Pharm., 1995, 119, (2), 231–238.
  • Bioavailability of theopylline from glutaraldehyde-crosslinked casein microspheres in rabits following oral administration. LATHA, M. S., RATHINAM, K., MOHANAN, P. V., and JAYAKRISHNAN, A., J. Controlled Release, 1995, 34, (1), 1–7.
  • The targeting of lectin-bearing liposomes to skin-associated bacteria. KASZUBA, M., LYLE, I. G., and JONES, M. N., Colloids Surf., B, 1995, 4, (3), 151–158.
  • Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin. Liu, D., Liu, F., and SONG, Y. K., Biochim. Biophys. Acta, 1995, 1235, (1), 140–164.
  • Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems. Lu, W., and PARK, T. G., PDA J. Pharm. Sci. Technol., 1995, 49, (1), 13–19.
  • Protection of lactate dehydrogenase against protease digestion by encapsulation in liposomes. NEMA, S., KIICK, D. M., and Avis, K. E., FDA J. Pharm. Sci. Technol., 1994, 48, (5), 231–235.
  • Spray-dried albumin microspheres containing nicardipine. CONTE, U., GIUNCHEDI, P., MAGGI, L., and TORRE, M. L., Eur. J. Pharm. Biopharm., 1994, 101, (4), 203–208.
  • Identification of some of the physicochemical characteristics of microspheres which influence the induction of the immune response following mucosal delivery. ALPAR, H. 0., ALMEIDA, A. J., Eur. J. Pharm. Biopharm., 1994, 101, (4), 198–202.
  • Factor affecting microencapsulation of drugs in liposomes. KULKARNI, S. B., BETAGERI, G. V., and SINGH, M., J. Microencapsulation, 1995, 12, (3), 229–246.
  • Advances in research on liposomes as transdermal drug delivery system. HUANG, S., WANG, D., and Fu, C., Zhongguo Yiyao Gongye Zazhi, 1994, 25, (11), 522–552.
  • Potential microencapsulation of pyrite by artificial inducement of ferric phosphate coatings. EVANGELOU, V. P., Y. Environ. Qual., 1995, 24, (3), 535–542.
  • Synthesis of anionic starch microspheres and their properties. Yu, J. G., TIAN, R. C., and Liu, Y. Q., Gaodeng Xuexiao Huaxue Xuebao, 1994, 15, (4), 616–619.
  • Intranasal immunization with liposomes induces strong mucosal immune responses in mice. VADOLAS, J., DAVIES, J. K., WRIGHT,P. J., and STRUGNELL, R. A., Eur. y. immunol., 1995, 25, (4), 969–975.
  • Endocytosis of poly(ethylene oxide)-modified liposome by human lymphoblastoid cells. HIGHASHI, N., and SUNAMOTO, J., Biochim. Biophys. Acta, 1995, 1243, (3), 386–923.
  • Rapid measurement of NH3 and weak acid permeation through liposomes and renal proximal tubule membranes. BAE, H. R., SUH, D. J., and LEE, S. H., Korean y. Physiol., 1994, 28, (2), 203–214.
  • The stability of proteinoid microspheres. MUELLER, H. U., and NICKEL, G., BioSystems, 1994, 33, (3), 215–220.
  • Immobilization and characterization of a liposome-mediated reconstituted nicotinic acetyl-choline receptor. SUH, J. I., PAIR, B. H., OH, S. Z., SUH, J. H., CHO, K. S., and PAIR, Y. K., 7. Biochem. Mol. Biol., 1995, 28, (2), 155–161.
  • Targeting chemotherapy using antibody-combined liposome against human pancreatic cancer cell-line. AKAISHI, S., KOBARI, M., TAKEDA, K., and MATSUNO, S., Tohoku 7. Exp. Med., 1995, 175, (1), 29–42.
  • Cytoxic effects of alkylphosphocholine-liposomes and macrophages on tumor cells. ZEISIG, R., JUNGMANN, S., F1CHTNER, I., DAEMEN, T., and ARNDT, D., Anticancer Res., 1994, 14, (5A), 1785–1790.
  • Reversal of multidrug resistance in human colon cancer cells expressing the human MDRI gene by liposomes in combination with monoclonal antibody or verapamil. SELA, S., HUSAIN, S. R., PEARSON, J. W., LONGO, D. L., RAHMAN, A., 7. Natl. Cancer Inst., 1995, 87, (2), 123–128.
  • Efficacy of gentamicin or ceftazidine entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumonia-infected lung tissue. BARKER, W. I. A. J. M., TEN, K. MT., STEARNE, C. L. E. T., and WOODLE, M. C., y. Infect. Dis., 1995, 171,(4), 938–947.
  • Uptake and binding of liposomal 2', 3'-dideoxycytidine by RAW 264.7 cells: A three-step process. MAKABI, P. B., LESSARD, C., BEAUCHAMP, D., DESORMEAUX, A., POULIN, L., TREMBLAY, M., and BERGERON, M. G., Acquired Immune Defic. Syndr. Hum. Retrovirol., 1995, 8, (3), 227–235.
  • Gene therapy using DC-Chol liposomes. GOYAL, K., and HUANG, L., 7. Liposome Res., 1995, 5, (1), 49–60.
  • Performance features for urea hydrolysis in a CSTR with microencapsulated urease. LEE, K. B., BOADI, D. K., and NEUFELD, R. J., Art if. Cells, Blood Substitutes, Immobilization Biotechnol., 1995, 23, (2), 207–292.
  • Relationship between the anchor structure of the galactosyl ligand for liposome modification and accumulation in the liver. MURAHASHI, N., SASAKI, A., HIGASHI, K., MORIKAWA, A., and YAMADA, H., Biol. Pharm. Bull., 1995, 18, (1), 82–88.
  • Influence of liposomal entrapping on analphylactic properties of allergens. ADO, A. D., FEDOSEYEVA, V. N., SEREBRENNIKOVA, G. A., GOLSTEIN, M. M., SHUSTOVA, V. I., AVDEYEVA, T. A., KRAVSCHENKO, S. A., and USHAKOVA, I. P., Patol. Fiziol. Eksp. Ter., 1993, (2), 3–5.
  • Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumors. MAYER, L. D., MASIN, D., NAYAR, R., BOMAN, N. L., and BALLY, M. B., Br. y. Cancer, 1995, 71, (3), 482–488.
  • Development of anticancer agent-releasing microcapsules for chemotherapy combined with embolo-hyperthermic therapy. MASAI, A., Nippon Igaku Hoshasen Gakkai Zasshi, 1995, 55, (1), 50–75.
  • Effects of encapsulation of chloramphenicol in albumin microspheres on its in vitro transfer across the human placenta. ONUR, M. A., VURAL, I., BASCI, N., PAMIR, R., COSKUN, T., IsImER, A., KAS, H. S., BEKSAC, S., HINCAL, A. A., and TUEMER,Microencapsulation, 1994,11, (6), 657.
  • Studies on adriamycin magnetic gelatin microspheres. Wu, C., WEI, S., Lu, W., HE, S., GAO, W., WANG, T., Li, X., and XIE, J., y. Chin. Pharm. Sci., 1995,4, (1), 1–7.
  • Biodistribution of liposomal amphoreticin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans. VAN ETTEN, E. W. M., OTTE, L. M., VAN VIANEN, W., TEN, K. M. T., and BAKKER, I. A. J. M..7. Antimicrob. Chemother., 1995, 35, (4), 509.
  • Pharmacokinetics of cisplatin albumin microspheres after embolizing in hepatic artery. Xu, F., JIANG, X., and ZHONG, Y., Zhongguo Yaoxue Zazhi, 1995, 30, (3), 144–147.
  • A new cationic liposome encapsulating genetic material. A potential delivery system for polynucleotides. PUYAL, C., MILHAUD, P., BIEVENUE, A., and PHILIPPOT, J. R., Eur. y. Biochem., 1995, 228, (3), 697–703.
  • Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes. BRISCOE, P., CANIGGIA, I., GRAVES, A., BENSON, B., HUANG, L., TANSWELL, A. K., and FREEMAN, B. A., Am. y. Physiol., 1995, 268, (3, Pt. 1), L374–380.
  • Macrophage depletion in the rat after intraperitioneal administration of liposome-encapsu-lated clodronate: depletion kinetics and accelerated repopulation of peritoneal and omental macrophages by administration of Freund's adjuvant. BIEWENGA, J., VAN DER ENDE, M. B., KRIST, L. F. G., BORST, A., GHUFRON, M., and VAN ROOIJEN, N., Cell Tissue Res., 1995, 280, (1), 189–196.
  • Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer's patch M cells. ERMAK, T. H., DOUGHERTY, E. P., BHAGAT, H. R., KABOK, Z., and PAPPO, J., Cell Tissue Res., 1995, 279, (2), 433–436.
  • Model of selective gene therapy of hair growth: liposome targeting of the active Lac-Z gene to hair follicles of histocultured skin. Li, L., and HOFFMAN, R. M., In Vitro Cell Dev. Biol.: Anim., 31, (1), 11–13.
  • Biodegradable Microspheres. 17. Lysosomal Degradation of Primaquine-Peptide Spacer Arms. BORISSOVA, R., STJAERNKVIST, P., KARLSSON, M. 0., and SJOEHOLM, 1., y. Pharm. Sci., 1995, 84, (2), 256–262.
  • Totally synthetic oxygen carrier. Liposome-embedded-heme. KOBAYASHI, K., Igaku no Ayumi, 1995, 172, (2), 105–108.
  • Liposomes: a drug carrier system for topical treatment in dermatology. SCHMID, M. H., and KORTI NG, H. C., Crit. Rev. Ther. Drug Carrier Syst., 1994, 11, (2&3), 97–118.
  • Preparation of microcapsules containing water-absorbent polymer and silicon carbide powder. TANAKA, M., SATO, H., KIMURA, I., and SAITO, N., Shikizai Kyokaishi, 1994, 67, (5), 300–311.
  • Synthesis of polyurethanes for microencapsulation. I. Chemcal modification of polyvinyl alcohol with alkyl isocryanates. BROSSE, C., HAMDAOU I, A. EL, SOUTIF, J. C., and BROSSE, J. C., Eur. Polym. y., 1995, 31, (5), 425–429.
  • Formation of wide range ordered arrangement in microsphere systems. TOKUSHIGE, K., and FUKUTOMI, T., Polym. y. (Tokyo), 1995, 27, (4), 414–419.
  • In vitro synergic effect of interferon gamma combined with liposomes containing muramyl tripeptide on human monocyte cytotoxicity against fresh allogeneic and autologous tumor cells. GALLIGIONI, E., SANTAROSA, M., FAVARO, D., SPADA, A., TALAMINI, R., and QUAIA, M., Tumori, 1994, 80, (5), 385–391.
  • Contributor of mannose receptor to signal transduction in Fc.gamma. receptor-mediated phagocytosis of mouse peritoneal macrophages induced by liposomes. MURAI, M., ARAMAKI, Y., and TSUCHIYA, S., y. Leukocyte Biol., 1995, 57, (4), 687–691.
  • Mucosal immunoadjuvant activity of liposomes: inducation of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes. DE HAAN, A., GEERLIGS, H. J., HUCHSHORN, J. P., VAN SCHARREN-BURG, G. J. M., PALACHE, A. M., and WII,SCHUT, J., Vaccine, 1995, 13, (2), 155–162.
  • Automated homogeneous liposome-based assay system for total complement activity. YAMAMOTO, S., KUBOTSU, K., KIDA, M., KONDO, K., MATSUURA, S., UCHIYAMA, S., aYONEKAWA, 0., and KANNO, T., Clin. Chem. (Washington, DC), 1995, 41, (4), 586–590.
  • Sphingolipid-dependent fusion of Semliki Forest virus with cholesterol-containing liposomes requires both the 3-hydroxyl group and the double bond of the sphingolipid backbone. CORVER, J., MOESBY, L., ERUKULLA, R. K., REDDY, K. C., BITTMAN, R., and WILSCHUT, J., .7. viol., 69, (5), 3220-3223.
  • The characterization of liposomal glucose oxidase electrodes for the measurement of glucose. TAYLOR, M. A., JONES, M. N., VADAGAMA, P.M., and HIGSON, S. P. J., Biosens. Bioelectron., 1995, 10, (3/4), 251–260.
  • Application of glucose biosensor to the perfusion culture of microencapsulated animal cells. CHEN, G., ZHU, D., Li, S., CHEN, P., Ji, X., and YUAN, Z., Shengwu Huaxue Yu Shengwu Wuli Xuebao, 1994, 26, (6), 609–614.
  • Novel surfactant-coated enzymes immobilized in poly(ethylene glycol) microcapsules. GOTO, M., MIYATA, M., KAMIYA, N., and NAKASHIO, F., Biotechnol. Tech., 1995, 9, (2), 81-84. Catalysis of the slow release microcapsule with alpha-amylase. WANG, Y BA, G., X1E, P., Wu, Z., and ZHANG, H., Mo Kexue Yu Yishu, 1994, 14, (3), 20–24.
  • Influence of phase behaviour of liposomes upon the specific binding between avidine and membrane bound model receptor. Liu, Z., WEN, C., and Su, S., Shengwu Huaxue Yu Shengwu Wuli Xuebao, 1994, 26, (5), 541–547.
  • Reversibility of the binding of cytochrome C to liposomes. Implications for lipid-protein interactions. RYTOMAA, M., and KINNUNEN, P. K. J., y. Biol. Chem., 1995, 270, (7), 3197–3202.
  • The effect of amphiphilic biocides contained in a medium on liposome membrane fluidity. PODOLAK, M., WAGA, S., and PRZESTALSKI, S., Pol. J. Environ. Stud., 1994, 3, (2), 23–27.
  • Transbilayer movement and net flux of cholesterol and cholesterol sulfate between liposomal membranes. RODRIGUEZA, W. V., WHEELER, J. J., KLIMUK, S. K., KITSON, C. N., and HOPE, M. J., Biochemistry, 1995, 34, (18), 6208–6217.
  • Cytochrome P-450 transfer from adrenocortical adrenocortical submitochondrial particles to liposome membranes. KOMINAMI, S., ONIZUKA, M., TASAKA, M. C., and TAKEMORI, S., Biochemistry, 1995, 34, (14), 4839–4548.
  • Interaction of theta toxin (perfringolysin 0), a cholesterol-binding cytolysin, with liposomal membranes: change in the aromatic side chains upon binding and insertion. NAKAMURA, M., SEKINO, N., IWAMOTO, M., OHNO, I. Y., Biochemistry, 1995, 34, (19), 6513–6520.
  • Protein-independent lead permeation through myelin lipid liposomes. DIAZ, R. S., and MONREAL, J., Mol. Pharmacol., 1995, 47, (4), 766–771.
  • Toxicity and biodistribution of liposomes of the main phospholipid from the archaebacterium Thermoplasma acidophilum in mice. FREISLEBEN, H. J., BORMANN, J., LITZINGER, D. C., LEHR, F., RUDOLPH, P., ScHATToN, W., and HUANG, L., J. Liposome Res., 1995, 5, (1), 215–223.
  • Effect of intravenous liposome-entrapped diphenylhydantoin in amygdaloid-kindled rats. OKA, M., MORI, N., and NIWA, S. I., ypn. J. Psychiatry Neurol., 1994, 48, (2), 426–427.
  • Liposome-mediated gene transfer into normal and dystrophin-deficient mouse myoblasts. TRIVEDI, R. A., and DICKSON, G., J. Neurochem., 1995, 64, (5), 2230–2238.
  • Drug effects on intraocular pressure and vascular flow in the bovine perfused eye using radiolabeled microspheres. MILLAR, J. C., WILSON, W. S., CARP, R. D., and HUMPHRIES, R. G., J. Ocul. Pharmacol. Ther., 1995, 11, (1), 11–23.
  • Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA. HEEREMANS, J. L. M., PREVOST, R., BEKKERS, M. E. A., Los, P., EMEIS, J. J., KLUFT, C., and CROMMELIN, D. J. A., Thromb. Haemostasis, 1995, 73, (3), 488–494.
  • Preclinical properties of N4-hexadecyl- and N4-octadecy1-1-beta-D- arabinofuranosylcytosine in liposomal preparations. SCHWENDENER, R. A., HORBER, D. H., OTTINGER, C., and SCHOTT, H., J. Liposome Res., 1995, 5, (1), 27–47.
  • An intramolecular disulfide bond is essential for annexin I-mediated liposome aggregation. Liu, L., and ZIMMERMAN, U. J. P., Biochem. Mol. Biol. Int., 1995, 35, (2), 345–350.
  • Alkylphosphocholines and alkylphosphocholine liposomes. ARNDT, D., ZEISIG, R., EUE, I., and FICHTNER, I., y. Liposome Res., 1995,5, (1), 91–98.
  • On the synthesis of oil-containing microcapsules and their electrolytic codeposition. ALEXANDRIDOU, S., KIPARISSIDES, C., FRANSAERA., and CELIS, J. P., Surf. Coat. Technol., 1995, 71, (3), 267–276.
  • Detection of lipopolysaccharides in phospholipids and liposomes using the Limulus test. SCHMIDTGEN, M., and BRANDL, M., J. Liposome Res., 1995, 5, (1), 109–161.
  • Indomethacin loaded PHEMA microspheres. Effect of drug concentration in the monomer-crosslinker mixture on the release kinetics. ORIENTI, I., GIANASI, E., AIEDEH, K., and ZECCHI, V., y. Pharm. Belg., 1995, 50, 11–18.
  • Quality improvement of spray-dried, protein-loaded D, L-PLA micropheres by appropriate polymer solvent selection. GANDER, B., WEHRLI, E., ALDER, R., and MERKLE, H. P., J. Microencapsulation, 1995, 12, (1), 83–97.
  • Polymer-coated liposomes: improved stability and release of cytosine arabinoside (Ara-C). SEHGAL, S., and ROGERS, J. A., J. Microencapsulation, 1995, 12, (1), 37–47.
  • Properties and drug release behaviour of poly(3-hydroxybutyric acid) and various poly(3-hy-droxybutyrate-hydroxyvalerate) copolymer microcapsules. GUERSEL, I., and HAS I RC I, V., J. Microencapsulation, 1995, 12, (2), 185–193.
  • Some factors affecting the size of Nylon 6-10 microcapsules prepared by interfacial polymerization in a high-voltage electric field. ETUK, B. R., WEATHERLEY, L. R., and MURRAY, K. R., y. Microencapsulation, 1995, 12, (2), 173–183.
  • Properties of multiphase microspheres of poly(D, L-lactic-co-glycolic acid) prepared by a potentiometric dispersion technique. O'DONNELL, P. B., IWATA, M., and MCGINITY, J. W. J. Microencapsulation, 1995, 12, (2), 155–163.
  • Monosialoganglioside GMI shortens the blood circulation time of liposomes in rats. Liu, D., Liu, F., and SONG, Y. K., Pharm. Res., 1995, 12, (4), 508–512.
  • Controlled nifedipine release from microcapsules of its dispersions in PVP-MCC and HPC-MCC. CHOWDARY, K. P. R., and RAMESH, K. V. R. N. S., Drug Dev. Ind. Pharm., 1995, 21, (10), 1183–1192.
  • Effects of varying drug loading on particle size distribution and drug release kinetics of verapamil hydrochloride microspheres prepared with cellulose esters. BHARDWAJ, S. B., SHUKLA, A. J., and COLLINS, C. C., y. Microencapsulation, 1995, 12, (1), 71–81.
  • Biodegradable microcapsules prepared by a w/o/w technique: effects of shear force to make a primary w/o emulsion on their morphology and protein release. SAH, H. K., TODDYWAI.A, R., and CHIEN, Y W., J. Microencapsulation, 1995, 12, (1), 59–59.
  • An experimental investigation of enzyme release from poly(vinyl alcohol) crosslinked microspheres. BACHTSI, A. R., and KIPARISSIDES, C., 7. Microencapsulation, 1995, 12, (1), 23–35.
  • Poloxamer-coated three-ply-walled microcapsules for controlled delivery of diclofenac sodium. BHATNAGAR, S., NAKHARE, S., and VYAS, S. P., y. Microencapsulation, 1995, 12, (1), 13–22.
  • A new method for the synthesis of smooth, round, hydrophilic protein microspheres using low concentrations of polymeric dispersing agents. LATHA, M. S., and JAYAKRISHNAN, A., y. Microencapsulation, 1995, 12, (1), 7–12.
  • Thermal analyzer and micro FT-IR/DSC system used to determined the protective ability of microencapsulated squid oil. LIN, S. Y., HWANG, L. S., and LIN, C. C., y. Microencapsulation, 1995, 12, (2), 165–172.
  • Liposomally encapsulated diclofenac for sonophoresis induced systemic delivery. VYAS, S. P., SINGH, R., and ASATI, R. K., y. Microencapsulation, 1995, 12, (2), 149–154.
  • Preparation of ethyl cellulose microcapsules containing theophylline by using emulsion non-solvent addition method. CHEN, H., Wu, J. C., and CHEN, H. Y., y. Microencapsulation, 1995, 12, (2), 137–147.
  • Lipsome-encapsulated alginate: controlled hydrogel particle formation and release. MONSHIPOURI, M., and RUDOLPH, A. 5,7. Microencapsulation, 1995, 12, (2), 117–127.
  • The study of polyethylene glycol-coated liposome containing adriamycin: the reasonable factor in avoiding reticuloenothelial system. SADZUKA, Y., NAKAI, D. I., MIYAGISHIMA, A., NOZAWA, Y.,and HIROTA, S., Drug Delivery Syst., 1994, 9, (6), 417–422.
  • Liposomal adjuvanticity: effect of encapsulation and surface linkage on antibody production and proliferative response. SHAHUM, E., and THERIEN, H., Int. y. Immunopharmacol., 1995, 17, (1), 9–20.
  • Incorporation efficiency determination of the capsular plague antigen into liposomes based on elastic light scattering. GUSEV, V. V., GUSEVA, N. P., and TATARINTSEV, S. N., Proc. SPIE-Int. Soc. opt. Eng., 1994, 2326, 475–478.
  • The past, present, and future uses of liposomes in treating infectious diseases. WASAN, K. M., and LOPEZ, B. G., Immunopharmacol. Immunotoxicol., 1995, 17, (I), 1–15.
  • Hollow glass microspheres. Application, properties, and technology (review). BUDOV, V. V., Steklo, Keram., 1994, 7–11.
  • Microencapsulation of antidegradants. WADDELL, W. H., and EVANS, L. R., Rubber World, 1994, 210, (5) 18–24.
  • Phase transition of microcapsule membranes induced by pH changes. UEDA, N., OHTA, R., TOGAWA, Y., MAKINO, K., KONDO, T., Polym. Gels. Networks, 1995, 3, (2), 135–143.
  • Preparation and use of monodisperse polymer microspheres. Omi, S., and MA, G., Kagaku Kogaku, 1995, 59, (3), 161–164.
  • Hierarchical structure of lattices in film formation of core-shell type polymer microspheres. ISHIZU, K., SUGITA, M., KOTSUBO, H., and SAITo, R., y. Colloid Interface Sci., 1995, 169, (2), 456–461.
  • Liposomes for controlled release in the food industry. REINECCIUS, G. A., ACS Symp. Ser., 1995, 590, (Encapsulation and Controlled Release of Food Ingredients), 113–31.
  • Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies. SALVADOR, L. G., BLAKE, M. S., MCCARTY, M., TAI, J. Y., and ZABRISKIE, J. B., y. Infect. Dis., 1995, 171, (3), 593–600.
  • Liposome immunoassay for bioactive substances. KIM, C. K., and PARK, K. M., Yakche Hakhoechi, 1994, 24, (4), 201–215.
  • Comparative kinetics of phospholipase A2 action on liposomes and monolayers of phos-phatidylcholine spread at the air-water interface. RANEVA, V., IVANOVA, T., VERGER, R., and PANAIOTOV, J., Colloids Surf., B, 1995, 3, (6), 357–369.
  • Effect of the osmotic conditions on the value of zeta potential of DMPC multilamellar liposomes. ALONSO, J. M., LLACER, C., VILA, A. 0., FIGUERUELO, J. E., and MOLINA, F. J., Colloids Surf, A, 1995, 95, (1), 11–14.
  • The optimum process conditions for liposome production determined using an orthogonal array experimental design. CHEN, W. K., WANG, C. H., and LEE, C. J. Chin. Inst. Eng., 1994, 17, (4), 513–520.
  • Amido- and carbamoyl-linked pseudoglyceryl lipids and liposomal dynamics. Moss, R. A., Li, J. M., and KOTCHEVAR, T., Langmuir, 1994, 10, (10), 3380–3382.
  • Effect of membrane surface potential on the uptake and the inhibition of cationic compounds in rat intestinal brush-border membrane vesicles and liposomes. SUGAWARA, M., OIKAWA, H., KOBAYASHI, M., SERI, K., and MIYAZAKI, K., Biochim. Biophys. Acta, 1995, 1234, (1), 22–28.
  • Antitumor effect of liposome-incorporated camptothecin in human malignant xenografts. DAOUD, S., S., FETOUH, M. I., and GIOVANELLA, B. C., Anti-Cancer Drugs, 1995, 6, (1), 83–93.
  • Liposome mediated transfer of marker and cytokine genes into rat and human glioblastoma cells in vitro and in vivo. RESZKA, R., ZHU, J. H., WEBER, F., WALTHER, W., GREFERATH, R., and DYBALLA, S.1. Liposome Res., 1995, 5, (1), 149–167.
  • /n vitro and in vivo antifungal activities of liposomal amphotericin B and amphotericin B lipid complex. MITSUTAKE, K., KOHNO, S., MIYAZAKI, Y., NODA, T., MIYAZAKI, H., MIYAZAKI, T., KAKU, M., KOGA, H., and HARA, K., Mycopathologia, 1994, 128, (1), 13–17.
  • The distribution and pharmacokinetics in lung of bovine serum albumin microspheres for pulmonary targeting in mice. ZHANG, M., HOU, S., GONG, T., CHENG, Y., and LIAO, G., Huaxi Yike Daxue Xuebao, 1994, 25, (4), 393–397.
  • Pharmacological effects of carboplatin-liposomes (CPL) in mice: a review of present knowledge. FICHTNER, I., RESZKA, R., GOAN, S. R., NAUNDORF, H., and HENTSCHEL, M., J. Liposome Res., 1995, 5 (1), 75–89.
  • High performance liquid chromatography of peptides on microspherical carbon column. YAMAKI, S., OKUYAMA, T., and SHINODA, T., Kuromatogurafi, 1994, 15, (4), 280–281. Turbulent and laminar drag of supefluid helium on an oscillating microsphere. JAEGER, J., SCHUDERER, B., and SCHOEPE, W., Phys. Rev. Lett., 74, (4), 566–569.
  • Determination of carboplatin in albumin microspheres by the chelating reaction-spectropho-tometry. ZHU, H., JIANG, X., YANG, Y., and ZHANG, W., Yaowu Fenxi Zazhi, 1995, 15, (1), 41–43.
  • Microcapsules through polymer complexation. Part 3: Encapsulation and culture of human Burkitt lymphoma cells in vitro. WEN, S., ALEXANDER, H., INCHIKEL, A., and STEVENSON, W. T. K., Biomaterials, 1995, 16., (4), 325–335.
  • Bovine serum albumin microspheres containing matrine and oxymatrine. CHEN, X., and SHI, T., junshi Yixue Kexueyuan Yuankan, 1995, 19, (I), 58–60.
  • A study of embolizing materials for chemo-embolization therapy of hepatocellular carci-noma: effects of particle size and dose on chitin-containing cis-diamminedichloroplat-inum(II) albumin microscphere antitumor activity in VX2 hepatic tumor model rabbits. NISHIOKA, Y., KYOTANI, S., OKAMURA, M., OHNISHI, S., YAMAMOTO, Y., KAWASHIMA, Y TANADA, S., TANADA, S., and NAKAMURA, T., Biol. Pharm. Bull., 17, (9), 1251-1255.
  • Formulation parameters of fluoroquinolone-loaded liposomes and in vitro antimicrobial activity. PUGLISI, G., FRESTA, M., MAZZONE, G., FURNERI, P., and TEMPERA, G., Intl. Pharm., 1995, 118, (1), 65–76.
  • Liposomes-based nasal delivery system of nifedipine: development and characterization. VYAS, S. P., GOSWAMI, S. K., and SINGH, R., Int. J. Pharm., 1995, 118, (1), 23–30.
  • Effects of drugs on the stability of phospholipid liposomal membranes. Kim, M., HAN, S. K., and KIM, C. K., Yakhak Hoechi, 1994, 38, (6), 637–645.
  • Effects of lipid composition on the properties of phospholipid liposomal membranes. Kim, M., HAN, S. K., and KIM, C., Yakhak Hoechi, 38, (2), 131–139.
  • Preparation of white beeswax microspheres loaded with valproic acid and kinetic study of drug release. GIANNOLA, L. I., DE CARO, V., CARO, V., RIZZO, M. C., Drug Dev. Ind. Pharm., 1995, 21, 793–807.
  • Polymerizable liposomes. I. Synthesis, and liposomes of two polymerizab le alpha, omega-dipo-lar amphiphiles having diyne moiety. Li, Z., HE, W., and Li, F., Gaofenxi Xuebao, 1995, (1), 113–116.
  • In vitro binary kinetics of sulfamethoxazole and trimethoprim microcapsules. GHOSAL, S. K., MAHURI, G., and PAL, T. K., Boll. Chim. Farm., 1992, 131, (1), 19–21.
  • Accelerated degradation test of lyophilized recombinant tissue factor-liposome preparations. VAN DEN BESSELAAR, A. M. H. P., WITTEVEEN, E., SCHAEFER VAN MANSFELD, H., MEEUWISSE BRAUN, J., and STREBUS, A., Thromb. Haemostasis, 1995, 73, (3), 392–397.
  • Effect of particle size on clearance of lipid microsphere in rats. IMAEDA, N., MATSUDA, H., TSUDA, Y., UEDA, Y., and YOKOYAMA, K., Drug Delivery Syst., 1994, 9, (5), 339–344.
  • Physicochemical characteristics of the interaction of liquid-crystal state liposome containing oleic acid and biomembrane. ZHANG, J., and SUN, R. G., Wuli Xuebao, 1994, 43, (9), 1495–1501.
  • Microencapsulated human hepatoma (HepG2) cells: capsule-to-capsule variations in protein secretion and permeability. ULUDAG, H., HWANG, J. R., and SEFTON, M. V., J. Controlled Release, 1995, 33, (2), 273–283.
  • Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein-encapsulated poly(DL-lactic acid-co-glycolic acid) microspheres. PARK, T. G., Lc, W., and CROTTS, G., J. Controlled Release, 1995, 33, (2), 211–222.
  • Measurement of penetration of hematoporphyrin derivative (HpD) encapsulated in liposomes into normal skin of female hairless rats by a tape stripping technique. FENAUX, M. L., NOTTER, D., LABRUDE, P., VIGNERON, C., and GUILLEMIN, F., Proc. SPIE-Int. Soc. Opt. Eng., 1994, 2328, (Biomedical Optoelectronic Devices and Systems II), 82–89.
  • Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres. SHAHIN, R., LEEF, M., ELDRIDGE, J., HUDSON, M., and GILLEY, R., Infect. Immun., 1995, 63, (4), 1195–1200.
  • A new drug carrier-starch microspheres. Hu, X., and Hoe, X., Zhongguo Yaoxue Zazhi, 1995, 30, (2), 69–71.
  • Medical application of synthetic phospholipids as liposomes and drugs. EIBL, H., and KAUFMANN, K. P., J. Liposome Res., 1995, 5, (1), 131–148.
  • Development of functional microcapsules. SENSHOKU KENKYU TAKAGISHI, T., 1994,38, (1), 7–14. In vivo induction of CD4 T cell responses by antigens covalently linked to synthetic micropheres does not require adjuvant. GENGOUX, C., and LECLERC, C., Int. Immunol., 7, (1), 45–53.
  • Delivery of Ti plasmid into Nicotiana sanderae protoplasts via liposomes. Lim, M. H., JEONG, J. D., and KIM, I. S., Ha'guk Nonghttia Hakhoechi, 1994, 37, (5), 343.
  • Immunoaffinity purification of inositol 1,4,5-trisphosphate receptor (subtype-I) from rat cerebellum and its functional reconstitution into liposomes. RHEE, S., K., LEE, C. H., and MIKOSHIBA, K., Mol. Cells, 1994, 4, (2), 335–413.
  • Spectral changes of neutral red in the system methemoglobin-liposomes. GORBENKO, G. P., Ukr. Biokhim. Zh., 1994, 66, (2), 59–63.
  • Kinetics of spreading of photodamaged DOPC liposomes at the air-water interface. RANEVA, V., I NVANOVA, T., LAZAROVA, G., PROUST, J., and PANAIOTOV, I., Colloid Polym. Sci., 1995, 273, (2), 150–155.
  • Human 5-lipoxygenase associates with phosphatidylcholine liposomes and modulates LTA4 synthetase activity. NOGUCHI, M., MIYANO, M., MATSUMOTO, T., and NOMA, M., Biochim. Biophys. Acta, 1994, 1215, (3), 300–306.
  • Interaction of stearylamine-liposomes with erythyrocyte ghosts: analysis of membrane lipid mixing and aqueous contents mixing, and the effect of carboxymethyl chitin on the interaction. NISHIYA, T., and LAM, R. T. T., Colloids Surf., B, 1995, 4, (1), 55–63.
  • Stability of pressure-extruded liposomes made from archaeobacterial ether lipids. CHOQUET, C. G., PATEL, G. B., BEVERIDGE, T. J., and SPROTT, G. D., Appl. Microbial. Biotechnol., 1994, 42, (2-3), 375–384.
  • Larvicidal and sporal behavior of Bacillus sphaericus 2362 in carrageenan microscapsules. MURAT, E. Y., and OEKTEMER, A., J. Controlled Release, 1995, 33, (2), 245–251.
  • Quantitative analysis of alachlor and atrazine in polymeric microcapsules determined by reverse-phase high performance thin layer chromatography with densitiometry. DAILEY, 0. D. JR., and JOHNSON, R. m., J. Liq. Chromatogr., 1995, 18, (5), 873–885.
  • Effect of metalloliposomes on the structural and functional state of cells in vitro and in vivo. KUNDIEV, Y. I., GRIGORIEVA, A. S., GORBON, L. N., VOLOBOEVA, A. A., CHEREDNICHENKO, V. M., and STEFANOV, A. V., Dopov. Akad. Nauk. Ukr., 1994, (4), 154–159.
  • Prevention of ovariectomy osteopenia in rats after vaginal administration of Hyaff 11 microspheres containing salmon calcitonin. BONUCCI, E., BALLANTI, P., RAMIRES, P. A., RICHARDSON, J. L., and BENEDETTI, L. M., Calcif. Tissue Int., 1995, 56, (4), 274–279.
  • Highly affinity of hybrid liposomes for normal human epidermal keratinocytes in vitro. MATSUMOTO, Y., YAMADA, E., KAMEI, S., IWAHARA, M., and UEOKA, R., Biol. Pharm. Bull., 1994, 17, (9), 1299–1300.
  • Protective effect of glycine against liposome membrane-perturbation and lysis induced by chlorpromazine. MORIMOTO, Y., and TAKEUCHI, Y., Chem. Pharm. Bull., 1994, 42, (9), 1890–1895.
  • Complement activation by alginate-polylysine microcapsules used for islet transplantation. DARQUY, S., PUEYO, M. E., CAPRON, F., and REACH, G., Artif. Organs., 1994, 18, (12), 898–903.
  • Therapeutic effect of reticuloendothelial system (RES)-avoiding liposomes containing a phospholipid analog of 5-fluorouracil, dipalmitoylphyosphatidylfluororidine, in Meth A sarcoma-bearing mice. Dot, K. OKU, N., TOYOTA, T., SHUTO, S., SAKI, A., ITOH, H., and OKADA, S., Biol. Pharm. Bull., 1994, 17, (10), 1414–1416.
  • Induction of serum tumor necrosis factor-alpha and interleukin-6 activity by liposome-encap-sulated muramyl tripeptide-phosphatidylethanolamine (L-MTP-PE) in normal cats. Fox, L. E., KING, R. R., SHI, F., KURZMAN, I. D., MACEWEN, E. G., and Kueus, P. S., Cancer Biother., 1994, 9, (4), 329–340.
  • Liposomes as tools in basic research and industry. PHILIPPOT, J., and SCHUBER, F., (Eds) (CRC Press, Boca Raton), 1995, 277, Comparative estimation of the liposomal content of phosphatidylcholine/triolein emulsions using fluorescence quenching and 1H-NMR techniques. KOMATSU, H., HANDA, T., and MIYAJIMA, K., Chem. Pharm. Bull., 1994, 42, (9), 1715–1719.
  • Study on hepatic artery chemoembolization using temperature-sensitive liposome or lipiodol emulsion. ONO, A., HORIKOSHI, I., and UENO, M., Biol. Pharm. Bull., 1995, 18, (2), 279–283.
  • Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study. UCHIDA, T., and GOTO, S., Biol. Pharm. Bull., 1994, 17, (9), 1272–1276.
  • The use of a high intensity utrasonic processor equipped with a flow cell in the production of reverse-phase liposomes. ARNARDOTTIR, H. B., SVEINSSON, S. J., and KRISTMUNDSDOTTIR, T., Int. 1. Pharm., 1995, 117, (2), 237–241.
  • Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes. GANGADHARAM, P. R., ASHTEKAR, D. R., FLASHER, D. L., DUZGUNES, N., Antimicrob. Agents Chemother., 1995, 39, (3), 725–730.
  • Kinetic analysis of endocytosis and intracellular fate of liposomes in single macrophages. YOSHIMUFtA, T., SHONO, M., IMAI, K., and HONG, K., y. Biochem. (Tokyo), 1995, 117, (1), 34–41.
  • Extension of delivery of microcapsules manufactured by the E-CAP pressure shock wave process. REDOING, B. K., JR., Spec. Publ. R. Soc. Chem., 1995, 161, 83–87.
  • Preparation and in vitro evaluation of of ganciclovir microspheres. MAHMOUD, H. A., Bull. Fac. Pharm. (Cairo Univ.), 1994, 32, (1), 79–83.
  • Preparation and evaluation of sustained release floctafenine microspheres for suspension formulations. HASHEM, F. M., Bull. Fac. Pharm. (Cairo Univ.), 1994, 32, (1), 73–78.
  • Ferrite plating on porous silica microspheres for ultrasonic contrast agents. ZHANG, M., ZHANG, Q., IToui, T., and ABE, M., IEEE Trans. Magn., 1994, 30, (6, Pt. 1), 4692–4694.
  • Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties. CANNILLO, J. A., MILSHTEIN, WOLF, G. L., and TORCHILIN, V., Magn. Reson. Imaging, 1995, 13, (1), 31–37.
  • Growth inhibition of macrophage-like other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro. MONKKONEN, TASKINEN, M., AURIOLA, S. 0. K., and URTT1, A., J. Drug Targeting, 1994, 2, (4), 299–308.
  • In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointesti-nal tract using polyglycerol esters of fatty acids and a poly(acrylic acid) derivative. AKIYAMA, Y., NAGAHARA, N., KASHIHARA, T., HIRAI, S., TOGUCHI, H., Pharm. Res., 1995, 12, (3), 397–405.
  • Evaluation of liposomal erythropoietin prepared with reverse-phase evaporation vesicle method by subcutaneous administration in rats. Qi, X., MAITANI, Y., SHIMODA, N., SAKAGUCHI, K., and NAGAI, T., Chem. Pharm. Bull., 1995, 43, (2), 295–299.
  • Thermodynamics of the partitioning of 7-chloro-4-(4'-methoxy) aminoquinoline and its cyclized analog in octanol-buffer and Liposome systems. Go, M. L., NGIAM, T. L., and ROGERS, J. A., Chem. Pharm. Bull., 1995, 43, (2), 289–294.
  • Dissolution properties of soybean lecithin microscapsules for short-term controlled release prepared using the Wurster process. FUKUMORI, Y., ICHI KAWA, H., JoNo, K., TOKUMI TSU, H., SHIMIZU, T., KANAMORI, R., TSUTSUMI, Y., NAKAMURA, K., MURATA, K. et al., Chem. Pharm. Bull., 1994, 42, (12), 2604–2611.
  • Pharmaceutical dosage form design of copoly(lactic/glycolic acid) microspheres. Mechanism of in vitro release of gentamicin. NAGATA, S., TAKESHIMA, K., HIRAO, K., and TAKAGISHI, Y., Yakugaku Zasshi, 1994, 114, (12), 1005–1014.
  • Mucoadhesion of polymer-coated liposomes to rat intestine in vitro. TAKEUCHI, H., YAmmuuro, H., NIWA, T., MN°, T., and KAWASHIMA, Y., Chem. Pharm. Bull., 42, (9), 1954.
  • Sterile filtration of liposomes: retention of encapsulated carboxyfluorescein. GOLDBACII, P., BROCHART, H., WEHRLE, 0., and STAMM, A., Int. J. Pharm., 1995, 117, (2), 225–302.
  • Egg and soya phospholipids-sonication and dialysis; a study on Liposome characterization. MEMOLI, A., PALERMITI, A., PALERMITI, L. G., TRAVAGLI, V., and ALHAIQUE, F., Int. J. Pharm., 1995, 117, (2), 159–163.
  • Controlled release of 1-beta-D-arabinofuranosylcytosine (ara-C) from hydrophilic gelatin microspheres: in vitro studies. ESPOSITO, E., PASTESINI, C., CORTESI, R., GAMBARI, R., MENEGATTI, E., and NASTRUZZI, C., Int. J. Pharm., 1995, 117, (2), 151–158.
  • Controlled-release kinetics of cimetidine microcapsules. SAHA, N., BHANJA, R. S., and PAL, T. K., Drug Delivery, 1995, 2, (1), 45–48.
  • Hypoglycemic effect of gelatin microspheres with entrapped insulin and protease inhibitor in normal and diabetic rats. NARAYANI, R., and RAO, P. K., Drug Delivery, 1995, 2, (I), 29–38. Study of liposomal drug delivery systems. Encapsulation efficiencies of some steroids in MLV liposomes. KULKARNI, S. B., VARGHA, B. E. I., Colloids Surf, B, 1995, 4, (2), 77–85.
  • Stability of mitoxantrone-containing liposomes. LAW, S. L., JANG, T. F., CHANG, P., LIN, F. M., Int. J. Pharm., 1995, 116, (1), 87–93.
  • Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. LEE, R. J., and Low, P. S., Biochim. Biophys. Acta, 1995, 1233, (2), 134–144.
  • The influence of certain additives and preparative conditions on surface adhesion of ethyl cellulose microcapsules containing isoniazid. EL HELW, A. M., Mansoura J. Pharm, Sci., 1994, 10, (2), 297–312.
  • The effect of free and liposome-encapsulated clodronate on the hepatic mononuclear phagocyte system in the rat. CAMILLERI, J. P., WILLIAMS, A. S., Amos, N., DOUGLAS-JONES, A. G., LOVE, W. G., and WILLIAMS, B. D., Clin. Exp. Immunol., 1995, 99, (2), 269–275.
  • Modulation of nonspecific antimicrobial resistance of mice to Klebsiella pneumoniae septicemia by liposome-encapsulated muramyl tripeptide phosphatidylethanolamine and interferon-gamma alone or combined. HAGEN, T. L. M. TEN, VIANEN, W. VAN, and BAKKER, W. I. A. J. M. J. Infect. Dis., 1995, 171, (2), 385–392.
  • In vitro release profiles of eristostatin from biodegradable polymeric microspheres: protein aggregation problem. Lu, W., and PARK, T., Biotechnol. Prog., 1995, 11, (2), 224–227.
  • Hemodynamic evaluation of recombinant human tumor necrosis factor (TNE)-alpha, TNF-SAM2 in and Liposomal TNE-SAM2 in an anesthetized dog model. LODATO, R. F., FEIG, B., AKIMARU, K., SOMA, G. I., and KLOSTERGAARD, J., J. Immunother. Emphasis Tumor Immunol., 1995, 17, (1)., 19–29.
  • Stripping rate of propionic acid from styrene-divinylbenzene copolymeric microcapsules with the tri-N-octyl amine as core material. YostilzAwA, H., UEMURA, Y., KAWANO, Y., and HATATE, Y., Solvent Extr. Ion. Exch., 1995, 13, (2), 333–351.
  • Preparation of monodispersed polystyrene microspheres uniformly coated by magnetite via heterogeneous polymerization. LEE, J., and SENNA, M., Colloid Polym. Sc., 1995, 273, (1), 76–82.
  • High-stability liposomes from macrocyclic diyne phospholipids. LADIKA, M., FISK, T. E., Wu, W. W., and JONS, S. D., J. Am. Chem. Soc., 1994, 116, (26), 12093–12094.
  • Partition of polysaccharide-coated liposomes in aqueous two-phase systems. KANG, E. C., AKIYOSHI, K., and SUNAMOTO, J., Int. J. Biol. Macromol., 1994, 16, (6), 348–353.
  • The iodide channel of the thyroid. II. Selective iodide conductance inserted into liposomes. GOLDSTEIN, P. E., SENSER, A., and BEAUWENS, R., Am. J. Physiol., 1995, 268, (1, Pt. 1), C111–C118.
  • Blue light-enhanced photosynthetic oxygen evolution from liposome-bound photosystem II particles: Possible role of the xanthophyll cycle in regulation of cyclic electron flow around photosystem II? GRUSZECK I, W. I., STRZALKA, K., RADUNZ, A., KRUK, J., and SCHMID, G. H., Z. Naturforsch., C: Biosci, 1995, 50, (1/2), 61–68.
  • Poly(ethylene glycol)-modified phospholipids prevent aggregation during covalent conjuga-tion of proteins to liposomes. HARASYM, T. 0., TARDI, P., LONGMAN, S. A., ANSELL, S. M., BALLY, M. B., CULLIS, P. R., and CHOI, L. S. L., Bioconjugate Chem., 1995, 6, (2), 187–194.
  • Diffuse optics determination of hemoglobin derivatives in red blood cells and liposome encapsulated hemoglobin. PHIRI, J. B., SENTHIL, V., and GROSSWEINER, L. I., Artif. Cells, Blood Substitutes, Immobilization Biotechnol., 1995, 23, (1), 23–38.
  • Measurement of the binding of DNA to liposomes by resonance energy transfer. Kolv, A., and KINNUNEN, P. K. J., J. Fluoresc., 1994, 4, (4), 345–347.
  • Characterization of a new reversed-phase chromatographic column on a 2 Ism porous microspherical silica gel. MORIYAMA, H., ANEGAYAMA, M., KOMIYA, K., and KATo-Y., y. Chromatogr., A, 1995, 691, (1-2), 81–9.
  • Neoglycoprotein-liposome and lectin-liposome conjugates as tools for carbohydrate recogni-tion research. YAMAZAKI, N., KODAMA, M. O., and GABIUS, H J., Methods Enzymol., 1994, 242, (Neoglycoconjugates, Pt. A), 56–65.
  • Sunscreens and T4N5 liposomes differ in their ability to protect against ultraviolet-induced sunburn cell formation, alterations of dendritic epidermal cells, and local suppression of contact hypersensitivity. WOLF, P., Cox, P., YAROSH, D. B., and KRIPKE, M. I., y. Invest. Dermatol., 1995, 104, (2), 287–292.
  • A structure-function study of bovine pancreatic phospholipase A2 using polymerized mixed liposomes. DuA, R., Wu, S., and Cm, W., J. Biol. Chem., 1995, 270, (1), 263–286.
  • Effects of inorganic phosphorus compounds on the hydrolysis of phosphatidylcholine liposomes by phospholipid-deacylating enzymes. Biotechnol. Appl. Biochem., 21, (1), 101–10.
  • Evidence for transbilayer, tail-to-tail cholesterol dimers in ciipalmitoylglycerophosphocline liposomes. HARRIS, J. S., EPPS, D. E., DAVIO, S. R., and KEZDY, F. J., Biochemistry, 1995,34, (11), 3851–3857.
  • Characterization of dimyristoylphosphatidylcholine liposome aggregates induced by dextran sulfate and La3+ by fluorescence spectroscopy. ZSCHOERNIG, 0., RICHTER, W., KRUM-BIEGEL, M., and ARNOLD, K., y. Fluoresc., 1994, 4, (4), 373–375.
  • Cationic multilamellar liposome-mediated gene transfer into primary myoblasts. KOJIMA, H., Oxism, N., TAKAMORI, M., and YAGI, K., Biochem. Biophys. Res. Commun., 1995, 207, (1), 8–12.
  • Protective effects of lipoPGE1, prostaglandin El incorporated in lipid microspheres, against liver injury caused by ischemia-reperfusion. EGASHIRA, T., TAKAYAMA, F., KUDO, Y YAMANAKA, Y., Nippon Yakurigaku Zasshi, 1995, 105, (2), 77–86.
  • Differential effect of triiodothyronine and thyroxine on the liposomal membrane in liquid-crystalline and gel state. FARIAS, R. N., CHEHIN, R. N., RINTOUL, M. R., and MORERO, R. D., y. Membr. Biol., 1995, 143, (2), 135–141.
  • The effect of liposome-entrapped triamcinolone on the bleomycin-induced lung injury in rats. LEDwozYw, A., and SYNOWIEC, R., Acta Physiol. Hung, 1994, 82, (3), 287–293.
  • Inhibition of human ovarian carcinoma cell proliferation by liposome-plasmid DNA complex. HOFLAND, H., and HUANG, L., Biochem. Biophys. Res. Commun., 1995, 207, (2), 492–496.
  • Bovine serum albumin (BSA) microspheres containing methotrexate H. Therapeutical effects on lung-bearing sarcoma-180 in mice. CHEN, X. P., and SHI, T. S., y. Chin. Pharm. Sci., 1994, 3, (2), 97–102.
  • Functional synergism of the magainins PGLa and magainin-2 in Escherichia coli, tumor cells and liposomes. WESTERHOFF, H. V., ZASLOFF, M., ROSNER, J. L., HENDLER, R. W., DE WAAL, A., VAZ, G. ANA., JONGSMA, A. P. M., RIETHORST, A., and JURETIC, D., Eur. Biochem., 1995, 228, (2), 257–264.
  • Kinetic modeling of liposome degradation in peritoneal macrophages. HARASHIMA, H., HIRAI, N., KIWADA, H., Biopharm. Drug Dispos., 1995, 16, (2), 113–123.
  • Liposomes as a tool in experimental pharmacology and toxicology. TEGTMEIER, M., WOELFEL, K., SOMMERLAD, C., and LEGRUM, W., Pharmazie, 1995, 50, (1), 73–74.
  • Touch-evoked agitation produced by spinally administered phospholipid emulsion and liposomes in rats. Structure-activity relation. YANEZ, A. M., WALLACE, M., Ho, R., SHEN, D., and YAKSH, T. L., Anesthesiology, 1995, 82, (5), 1189–1198.
  • Biodegradable microspheres. 16. Synthesis of primaquine-peptide spacers for lysosomal release from starch microparticles. BORISSOVA, R., LAMMEK, B., STJARNKVIST, P., and SJOHOLM, J., y. Pharm. Sci., 1995, 84, (2), 249–255.
  • Pharmacokinetics and body distribution of liposomal zinc phthalocyanine in tumor-bearing mice: influence of aggregation state, particle size, and composition. ISELE, U., SCHIEWECK, K., KESSLER, R., VAN HOOGEVEST, P., and CAPRARO, H. G., y. Pharm. Sci., 1995, 84, (2), 166–173.
  • Fourier transform infrared spectroscopic studies of cross-linked human serum albumin microcapsules. 3. Influence of terephthaloyl chloride concentration on spectra and correlation with microcapsule morphology and size. LEVY, M. C., LEFEBVRE, S., ANDRY, M. C., and MANFAIT, M.,.7. Pharm. Sci., 1995, 84, (2), 161–165.
  • Histopathologic study following administration of liposome-encapsulated hemoglobin in the normovolemic rat. RUDOLPH, A. S., SPIELBERG, H., SPARGO, B. J., and KossovsKy, N.,.7. Biomed. Mater. Res., 1995, 29, (2), 189–196.
  • Staurosporine encapsulated into pH-sensitive liposomes reduces tnf production and increases survival in rat endotoxin shock. TSCHAIKOWSKY, K., and BRAIN, J. D., Shock, 1994, 1, (6), 401–407.
  • Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts-an alternate approach to somatic gene therapy. AL HENDY, A., HORTELANO, G., TANNENBAUM, G. S., and CHANG, P. L., Hum. Gene. Ther., 1995, 6, (2), 165-175. Cellular pharmacology of a liposomal preparation of N4-hexadecy1-1-beta-D-arabinofura-nosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine. HORBER, D. H., SCHOTT, H., and SCHWENDENER, R. A., Br. y. Cancer, 1995, 71, (5), 957-962. Differential effect of triiodothyronine and thyroxine on the liposomal membrane in liquid-crystalline and gel state. FARIAS, R. N., CHEH1N, R. N., RINTOUL, M. R., and MORERO, R. D., y. Membr. Biol., 1995, 143, (2), 135–141.
  • Comparative capacity of four antifungal agents to stimulate murine macrophages to produce tumour necrosis factor alpha: an effect that is attenuated by pentoxifylline, liposomal vesicles, and dexamethasone. LOUIE, A., BALTCH, A. L., FRANKE, M. A., SMITH, R. P., and GORDON, M. A., y. Antimicrob. Chemother., 1994, 34, (6), 975–987.
  • Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis. ALLEN, S. D., SORENSEN, K. N., NEJDL, M. J., DURRANT, C., and PROFFIT, R. T., J. Antimicrob. Chemother., 1994, 34, (6), 1001–1013.
  • Successful treatment of focal hepatic candidiasis with liposomal amphotericin B. O'CONNELL, B., CROTTY, G., CAFFERKEY, M. T., STEPHENS, R., MCDONALD, G. S., and MCCANN, S. R., Jr. J. Med. Sci., 1992, 161, (12), 664–665.
  • Oligomannose-coated liposomes as an adjuvant for the induction of cell-mediated immunity. SUGIMOTO, M., OHISHI, K., FUKASA WA, M., SHIKATA, K., KAWAL H., ITAKUFtA, H., HATANAKA, M., SAKAKIBARA, R., IsHicuRo, M., NAKATA, M., FEBS-Lett., 1995, 363, (1-2), 53–56.
  • Pulmonary toxicity during infusion of liposomal amphotericin B in two patients with acute leukemia. ARNING, M., HEER SONDERHOFF, A. H., WEHMEIER, A., and SCHNEIDER, W., Eur. y. Clin. Microbial. Infect. Dis., 1995, 14, (1), 41–43.
  • The effect of liposomally conjugated methotrexate upon mediator release from human peripheral blood monocytes. WILLIAMS, A. S., PUNN, Y. L., Amos, N., COOPER, A. M., and WILLIAMS, B. D., Br. y. Rheumatol., 1995, 34, (3), 241–245.
  • Efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus (letter). TORRE, C. J., and Vi LLANUEVA, J. L., Clin. Infect. Dis., 1995, 20, (1), 191.
  • Liposomes in drug targeting. BASU, M. K., Biotechnol. Genet. Eng. Rev., 1994, 12, 383-408. Successful allotransplantation of microencapsulated parathyroids in rats. HASSE, C., SCHREZEN- MEIR, J., STINNER, B., SCHARK, C., WAGNER, P. K., NEUTMANN, K., and ROTHMUND, M., World J. Surg., 1994, 18, (40), 630–634.
  • Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. WANG, S., LEE, R. J., CAUCHON, G., GORENSTEIN, D. G., and Low, P. S., Proc. Natl. Acad. Sci. USA, 1995, 92, (8), 3318–3322.
  • Rates of systemic degradation and reticuloendothelial system uptake of calcein in the dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols in mice. Qi, X. R., MAITANI, Y., and NAGAI, T., Pharm. Res., 1995, 12, (1), 49–52.
  • Liposome-mediated gene transfer into normal and dystrophin-deficient mouse myoblasts. TRIVEDI, R. A., and DICKSON, G., J. Neurochem., 1995, 64, (5), 2230–2238.
  • Contribution of mannose receptor to signal transduction in Fc gamma receptor-mediated phagocytosis of mouse peritoneal macrophages induced by liposomes. MURAI, M., ARAMAKI, Y., and TSUCHIYA, S., y. Leukoc. Biol., 1995, 57, (4), 687–691.
  • Control of intensity of light coagulation by thermo-induced release of a fluorescent marker encapsulated in liposomes. /n vivo/ex vivo preliminary study. DESMETTRE, T., MORDON, S., DEVOISELLj. M., CONSTANTINIDES, G., BRUNETAUD, J. m.,y, Fr.Opthtalmol., 1994, 17,(12), 774–807.
  • Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution. PEREIRA, F. B., GoNi, F. M., and NiEvA, J. L., FEBS-Lett., 1995, 362, (2), 243-246. Automated homogeneous liposome-based assay system for total complement activity. YAMAMOTO, S., KUBOTSU, K., KIDA, M., KONDO, K., MATSUURA, S., LTCHIYAMA, S., YONEKAWA, 0., and KANNOL, T., Clin. Chem., 1995, 41, (4), 586–590.
  • Diffuse optics determination of hemoglobin derivatives in red blood cells and liposome encapsulated hemoglobin. PHIRI, J. B., SENTHIL, V., and GROSSWEINER, L. I., Artif. Cells Blood Substit. Immobil. Biotechnol., 1995, 23, (1), 23–38.
  • Induction of serum tumor necrosis factor-alpha and interleukin-6 activity by liposome-encap-sulated muramyl tripeptide-phosphatidylethyanolamine (L-MTP-PE) in normal cats. Fox, L. E., KING, R. R., SHI, F., KURZMAN, I. D., MACEWEN, E. G., and KUBILIS, P. S., Cancer Biother., 1994, 9, (4), 329–340.
  • Liposomes as delivery systems in the prevention and treatment of infectious diseases. BERGERS, J. J., TEN HAGEN, T. L., VAN ETTEN, E. W., and BAKKER WOUDENBERG, I. A., Pharm. World Sci., 1995, 17, (1), 1–11.
  • In vivo induction of CD4 + T cell responses by antigens covalently linked to synthetic microspheres does not require adjuvant. GENGOUX, C., and LECLERC., C., Int. Immunol., 1995, 7, (1), 45–53.
  • Sustained expression of functional nerve growth factor in primary septo-hippocampal cell cultures by liposome-mediated gene transfer. YANG, K., FAUSTINELLA, F., XUE, J. J., WHITSON, J KAMPFL, A., Mu, X. S., ZHAO, X., TAGLIALATELA, G., PEREZ POLO, .1. R., CLIFTON, G., Neurosci., Lett., 1994, 182, (2), 291–294.
  • Optimizing liposome-mediated gene transfer in primary rat septo-hippocampal cell cultures. YANG, K., FAUSTINELLA, F., XUE, J. J., WHITSON, J., KAMPFL, A., Mu, X. S., ZHAO, X., TAGLIALATELA, G., PEREZ POLO, J. R., CLIFTON, G., Neurosci. Lett., 1994, 182, (2), 287–290.
  • Comparison of laser Doppler flowmeter and radioactive microspheres in measuring blood flow in in pig skin flaps. RIVAL, R., BANCE, M., ANTONYSHYN, 0., PHILLIPS, J., and PANG, C. Y., Laryngoscope, 1995, 105, (4 Pt 1), 383–386.
  • Regional cerebral tissue blood flow measured by the colored microsphere method during retrograde cerebral perfusion. 00HARA, K., Usui, A. MURASE, M., TANAKA, M., and ABE, T., .7. Thorac. Cardiovasc. Surg., 1995, 109, (4), 772–779.
  • Spinal controlled delivery of bupivacaine from DL-lactic acid oligomer microspheres. LE CORRE, P., ESTEBE, J. P., CHEVANNE, F., MALLEDANT, Y., and LE VERGE, R.,.7. Pharm. Sci., 1995, 84, (1), 75–78.
  • Liposomes as in-vivo carriers for citicoline: effects on rat cerebral post-ischaemic reperfusion. FRESTA, M., PUGLISI, G., DI GIACOMO, C., and Russo, A.,I. Pharmacol., 1994,46, (12), 974–981.
  • Antiproliferative activity of liposomal epirubicin on experimental human gliomas in vitro and in vivo after intratumoral/interstitial application. TODOROV, D. K., NINJO, S. S., and ZELLER, W. J.,.7. Cancer Res. Clin. Oncol., 1995, 121, (3), 164–168.
  • Use of liposome preparation to treat mycobacterial infections. BERMUDEZ, L. E., Immunobiology, 1994, 191, (4-5), 578–583.
  • Liposomal tretinoin for uncomplicated acne vulgaris. SCHAFER KORTING, M., KORTING, H. C., and PONCE POSCHL, E., Clin. Investig., 1994, 72, (12), 1086–1091.
  • Delivery of a secretable adenosine deaminase through microcapsules-a novel approach to somatic gene therapy. HUGHES, M., VASSILAKOS, A., ANDREWS, D. W., HORTELANO, G., BELMONT, J. W., and CHANG, P. L., Hum. Gene Ther., 1994, 5, (12), 1445–1455.
  • Effects of inorganic phosphorus compounds on the hydrolysis of phosphatidylcholine liposomes by phospholipid-deacylating enzymes. SULTANA, G. N., WATANABE, Y., and TAMAI, Y., Biotechnol. Appl. Biochem., 1995, 21, (Pt 1), 101–110.
  • Liposome mediated modulation of macrophage functions. VAN RoolJEN, N., Adv. Exp. Med. Biol., 1994, 355, 69–74.
  • A novel liposome immune lysis assay (LILA) for determination of CRP antigen using two monoclonal antibodies recognizing different antigen determinants. UMEDA, M., and YASUDA, T., Acta Med. Okayama, 1994, 48, (6), 299–304.
  • Intra-arterial admininstration of adriamycin-loaded albumin microspheres for locally advanced breast cancer. DOUGHTY, J. C., ANDERSON, J. H., WILLMOTT, N., and MCARDLE, C. S., Postgrad. Med. y., 1995, 71, (831), 47–49.
  • Sphingolipid-dependent fusion of Semliki Forest virus with cholesterol-containing liposomes requires both the 3-hydroxyl group and the double bond of the sphingolipid backbone. CORVER, J., MOESBY, L., ERUKULLA, R. K., REDDY, K. C., BITTMAN, R., and WILSCHUT, J., y. Virol., 1995, 69, (5), 3220–3223.
  • Reversal of multicirug resistance in human colon cancer cells expressing the human MDRI gene by liposomes in combination with monocolonal antibody or verapamil (see comments). SELA, S., HUSAIN, S. R., PEARSON, J. W., LONGO, D. L., and RAHMAN, A.J. Natl. Cancer Inst., 1995, 87, (2), 123–128.
  • A fusogenic protein from rat brain microsomal membranes: partial purification and reconstitution into liposomes. RAKOWSKA, M., ZBOROWSK I, J., and CORAZZI, L., Membr., 1994, 142, (1), 35–42.
  • Reconstitution of 5'-nucleotidase of bull seminal plasma in spin-labeled liposomes. FINI, C., THUONG, V. D., ALIANTE, M., FLORID, A., and CANNISTRARO, S.,.7. Membr. Biol., 1994, 142, (1), 137–144.
  • Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. GILL, P. S., ESPINA, B. M., MUGGIA, F., CABRIALES, S., TULPULE, A., ESPLIN, J. A., LIEBMAN, H. A., FORSSEN, E., Ross, M. E., and LEVINE, A. M., y. Clin. Oncol., 1995, 13, (4), 996–1003.
  • Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma. HARRISON, M., TOMLINSON, D., and STEWART, S.,3. Clin. Oncol., 1995, 13, (4), 914–920.
  • Highly efficient transfection into primary cultured mouse hepatocytes by use of cation-lipo-somes: an application for immunization. WATANABE, Y., NOMOTO, H., TAKEZAWA, R., MIYOSHI, N., and AKAIKE, T., y. Biochem. (Tokyo), 1994, 116, (6), 1220–1226.
  • A comparison of the in vitro activity of amphotericin B with that of liposomal amphotericin B against Candida albicans colonising central venous catheters (letter). TEBBS, S. E., VEALE, E. L., and ELLIOTT, T. S., y. Antimicrob. Chemother., 1994, 34, (5), 840–841.
  • Functional synergism of the magainins PGLa and magainin-2 in Escherichia coli, tumour cells and liposomes. WESTERHOFF, H. V., ZASLOFF, M., ROSNER, J. L., HENDLER, R. W., DE WAAL, A., VAZ GOMES, A., JONGSMA, P. M., RIETHORST, A., and JURETIC, D., Eur. y. Biochem., 1995, 22.8, (2), 257–264.
  • Treatment of neurodermatitis with liposomes (letter). Dtsch. Med. Wochenschr., 1995, 120, (12), 425.
  • Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery. MCCORMACK, B., and GREGORIADIS, G., I. Drug. Target., 1994, 2, (5), 449–454.
  • Liposomes, an interesting tool to deliver a bioenergetic substrate (ATP), in in vitro and in vivo studies. PUISIEUX, F., FATTAL, E., LAHIANI, M., AUGER, J., JOUANNET, P., COUVREUR, P., and DELATTRE, J., Y. Drug. Target., 1994, 2, (5), 443–448.
  • Liposomes in pulmonary applications: physiciochemical considerations, pulmonary distri-bution and antioxidant delivery. SHEK, P. N., SUNTRES, Z. E., and BROOKS, J. I., J. Drug. Target., 1994, 2, (5), 431–442.•
  • Interation of liposomal incorporated vitamin D3-analogues and human keratinocytes. PRUFER, K., MERZ, K., BARTH, A., WOLL1NA, U., and STERNBERG, S., J. Drug. Target., 1994, 2, (5), 419–429.
  • Incorporation of vitamin D3-derivatives in liposomes of different lipid types. MERZ, K., and STERNBERG, B., J. Drug. Target., 1994, 2, (5), 411–417.
  • Liposomes: a novel topical delivery system for pharmaceutical and cosmetic applications. WEINER, N., LIEB, L., NIEMIEC, S., RAMACHANDRAN, C., Hu, Z., and EGBARIA, K., J. Drug. Target., 1994, 2, (5), 405–410.
  • Sterically stabilized liposomes: physical and biological properties. WOODLE, M. C., NEWMAN, M. S., and COHEN, J. A., 5. Drug. Target., 1994, 2, (5), 397–403.
  • Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: a progress review. MACEWEN, E. G., KURZMAN, I. D., HELFAND, S., VAII„ D., LONDON, C., KISSEBERTH, W., ROSENTHAL, R. C., Fox, L. E., KELLER, E. T., OBRADOVICH, J., 5. Drug. Target., 1994, 2, (5), 391–396.
  • The use of phospholipid liposomes for targeting to oral and skin-associated bacteria. JONES, M. N., KASZUBA, M., HILL, K. J., SONG, Y. H., and CREETH, J. E., 5. Drug. Target., 1994, 2, (5), 381–389.
  • The interaction of liposomal amphotericin B and serum lipoproteins within the biological milieu. WASAN, K. M., and LOPEZ BERESTEIN, G., 5. Drug. Target., 1994, 2, (5), 373–380.
  • Liposomes in the treatment of infections. BARKER WOUDENBERG, I. A., STORM, G., and WOODLE, M. C., 5. Drug. Target., 1994, 2, (5), 363–371.
  • Liposome mediated depletion of macrophages: an approach for fundamental studies. Bu ITING, A. M., and VAN R0I:A.1EN, N., 5. Drug. Target., 1994, 2, (5), 357–362.
  • The immunological adjuvant and vaccine carrier properties of liposomes. GREGORIADIS, G., 5. Drug. Target., 1994, 2, (5), 351–356.
  • Model of selective gene therapy of hair growth: liposome targeting of the active Lac-Z gene to hair follicles of histocultured skin (letter). Li, Land HOFFMAN, R. M., In Vitro Cell Dev. Biol. Anim., 1995, 31, (1), 11–13.
  • Administration of liposomal MTP-PE by the local physician: the role of the research nurse. GANO, J. B., and KLEINERMAN, E. S., Cancer Pract., 1995, 3, (1), 42–46.
  • Pharmacokinetics of liposomal amphotericin B (AmBisome) versus other lipid-based formulations. HEINEMANN, V., KAHNY, B., DEBUS, A., WACHHOLZ, K., and JEHN, U., Bone Marrow Transplant, 1994, 14, Suppl 5, S8–S9.
  • Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin. RINGDEN, 0., ANDSTROM, E., REMBERGER, M SVAHN, B. M .,and TOLLERMAR, J., Bone Marrow Transplant, 1994, 14, Suppl 5, S10–S14.
  • Microencapsulation of DNA within alginate microspheres and crosslinked chitosan mem-branes for in vivo application. ALEXAKIS, T., BOADI, D. K., QUONG, D., GROBOILLOT, A., O'NEILL, I., PONCELET, D., and NEU/T.1,D, R. J Appl. Biochem. Biotechnol., 1995, 50,(1), 93–106.
  • Evaluation of a liposome system for the deliVery of desferrioxamine to lungs in rats. TABAK, A., HOFFER, E., and TAITELMAN, U., 5. Pharm. Pharmacol., 1994, 46, (10), 789–796.
  • Development and characterization of a liposome preparation by a pH-gradient method. VEMURI, S., and RHODES, C. T., 5. Pharm. Pharmacol., 1994, 46, (10), 788–783.
  • Hand-foot syndrome associated with liposome-encapsulated doxorubin therapy. GORDON, K. B., TAJUDDIN, A., GUITART, J., KUZEL, T. M., ERAMO, L. R., and VON ROENN, I., Cancer, 1995, 75, (8), 2169–2173.
  • In vitro effects of brain derived neurotrophic factor released from microspheres. MITTAL, S., COHEN, A., and MAYSINGER, D., Neuroreport., 1994, 5, (18), 2577–2582.
  • Design and applications of a new fluorimetric assay of thioguanine in liposomes. FORADADA, M., GALLARDO, M., and ESTELRICH, J., 5. Pharm. Biomed. Anal., 1994, 12, (12), 1495–1499.
  • Liposomal amphotericin B for postoperative Aspergillus fumigatus endocarditis. Ann. Thorac. Surg., 1995, 59, (4), 1015–1017.
  • Chloroquine encapsulated in malaria-infected erythrocyte-specific anti-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice. OW Al, M., VARSHNEY, G. C., CHOUDHURY, A., CHANDRA, S., and GUPTA, C. M., Antimicrob. Agents Chemother., 1995, 39, (1), 180–184.
  • Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobac-terium avium beige mouse model. LE CONTE, P., LE GALLOU, F., PoTEL, G., STRUILLOU, L., BARON, D., and DRUGEON, H. B., Antimicrob. Agents Chemother., 1994, 38, (12), 2695–2701.
  • Detergent, liposome, and micelle-assisted protein refolding. ZARDENETA, G., and HOROWITZ, P. M., Anal. Biochem., 1994, 223, (1), 1–6.
  • Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes. BRISCOE, P., CANIGGIA, I., GRAVES, A., BENSON, B., HUANG, L., TANSWELL, A. K., and FREEMAN, B. A., Am. J. Physiol., 1995, 268, (3 Pt 1), L374–L380.
  • Efficacy of lipsomal mummy) tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma. KLEINERMAN, E. S., GANO, J. B., JOHNSTON, D. A., BENJAMIN, R. S., and JAFFE, N., Am. J. Clin. Oncol., 1995, 18, (2), 93–99.
  • Fornation and characterization of cisplatin-loaded poly(benzyl 1-glutamate) microspheres for chemoembolization. Li, C., YANG, D. J., NIKIFOROW, S., TANSEY, W., KUANG, L. R., WRIGHT, K. C., and WALLACE, S., Pharm. Res., 1994, 11, (12), 1792–1799.
  • Development of anticancer-agent-releasing microcapsules for chemotherapy combined with embolo-hyperthermic therapy. MASAI, A., Nippon Igaku Hoshasen Gakkai Zasshi, 1995, 55, (1), 50–57.
  • Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties. TRUBRESKOY, V. S., CANNILLO, J. A., MILsHTEIN, A., WOLF, G. L., and TORCHILIN, V. P., Magn. Reson. Imaging, 1995, 13, (1), 31–37.
  • Use of liposomes in early treatment of experimental wounds. SHRAER, T. I., SHAPOSHNIKOV, I., and KREINES, V. M., Khirurgiia (Mosk), 1994, (12), 35–38.
  • Casein as a carrier matrix for 5-fluorouracil: drug release from microspheres, drug-protein conjugates and in-vivo degradation of microspheres in rat muscle. LATHA, M. S., JAYAKRISHNAN, A., RATHINAM, K., and MOHANTY, M., y. Pharm. Pharmacol., 1994, 46, (11), 858–862.
  • Nosocomial infection due to enterococci attributed to a fluidized microsphere bed (letter). CLANCY, M. J., J. Hasp. Infect., 1994, 28, (4), 324–325.
  • Copper-induced lipid peroxiciation in liposomes, micelles, and LDL: which is the role vitamin E? MAIORINO, M., ZAMBURLINI, A., ROVERI, A., and URSINI, F., 18, (1), 67–74.
  • Equilibrium and kinetic parameters for the interaction of a monoclonal antibody with liposomes bearing fluorescent haptens. PETROSSIAN, A., Cell. Biophys., 1993, 23, (1-3), 111–137.
  • Measurement of organ blood flow with coloured microspheres in the rat. HAKKINEN, J. P., MILLER, M. W., SMITH, A. H., and KNIGHT, D. R., Cardiovasc. Res., 1995, 29, (1), 74-79. Photoactivated enhancement of liposome fusion. BENNETT, D. E., and O'BRIEN, D. F., Biochemistry, 1995, 34, (9), 3102–3113.
  • Effect of cholesterol, fatty acyl chain composition, and bilayer curvature on the interaction of cytochrome b5 with liposomes of phosphatidylcholines. TAYLOR, K. M., and ROSEMAN, M. A., Biochemistry, 1995, 34, (11), 3841–3850.
  • Kinetics of uptake, transport, and accumulation of liposome-associated fluorescent dolichol esters in human fibroblasts. JIANG, L., and RIP, J. W., Biochem. Cell Biol., 1994, 72, (7-8), 283–288.
  • Investigation of liposome-based immunomigration sensors for the detection of polychlori-nated biphenyls. ROBERTS, M. A., and DURST, R. A., Anal. Chem., 1995, 67, (3), 482–491.
  • Neoglycoprotein-liposome and lectin-liposome conjugates as tools for carbohydrate recogni-tion research. YAMAZAKI, N., KODAMA, M., and GABIUS, H. J., Methods Enzymol., 1994, 242, 56–65.
  • Large-scale production of liposomes containing monomeric zinc phthalocyanine by con-trolled dilution of organic solvents. ISELE, U., VAN HOOGEVEST, P., HILFIKER, R., CAPRARO, H, G., SCHIEWECK, K., and LEUENBERGER, H., J. Pharm. Sci., 1994, 83, (11), 1608–1616.
  • pH-independent controlled-release microspheres using polyglycerol esters of fatty acids. AKIYAMA, Y., YOSHIOKA, M., HORIBE, H., HIRAI, S., KITAMORI, N., andToGucHI, H., y. Pharm. Sci., 1994, 83, (11), 1600–1607.
  • Induction of specific IgA responses in rats after oral vaccination with biodegradable microspheres containing a recombinant protein. MUIR, W., HUSBAND, A. J., GIPPS, E. M., and BRADLEY, M. P., Immunol. Lett., 1994, 42, (3), 203–207.
  • Modulation of phospholipase A2 activity by membrane-active peptides on liposomes of different phospholipid composition. GASONOV, S. E., RAEL, E. D., MARTINEZ, M., BAEZA, G., and VERNON, L. P., Gen. Physiol. Biophys., 1994, 13, (4), 275–286.
  • Comparison of cellular accumulation, tissue distribution,, and anti-HIV activity of free and liposomal 2',3'-dideoxycytidine. MAKABI PANZU, B., LESSARD, C., PERRON, S., DESORMEAUX, A., TREMBLAY, M., POULIN, L., BEAUCHAMP, D., and BERGERON, M. G., AIDS Res. Hum. Retroviruses, 1994, 10, (110, 1463–1470.
  • Catecholamine-containing biodegradable microsphere implants as a novel approach in the treatment of CNS neurodegenerative disease. A review of experimental studies in DA-lesioned rats. MuRAE, A., LING, E. A., HJORTH, S., DAHLSTROM, A., MASON, D., and TICE, T., Mol. Neurobiol., 1994, 9, (1-3), 191–205.
  • Attachment of monophosphoryl lipid A (MPL) to cells and liposomes augments antibody response to membrane-bound gangliosides. RAVINDRANATH, M. H., MORTON, D. L., and IRIE, R. F., J. Autoimmum., 1994, 7, (6), 803–816.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.